A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of the selective aurora kinase inhibitor GSK1070916A.
Iain McNeish
No relevant relationships to disclose
Alan Anthoney
No relevant relationships to disclose
Paul Loadman
No relevant relationships to disclose
Dan Berney
No relevant relationships to disclose
Simon Joel
No relevant relationships to disclose
Sarah E. R. Halford
No relevant relationships to disclose
Emily Buxton
No relevant relationships to disclose
Amanda Race
No relevant relationships to disclose
Mohammed Ikram
No relevant relationships to disclose
Andrew Scarsbrook
No relevant relationships to disclose
Angela Patikis
No relevant relationships to disclose
Andrea Rockall
No relevant relationships to disclose
Nicola A Dobbs
No relevant relationships to disclose
Christopher Twelves
No relevant relationships to disclose